CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
February 2019—ChromaCode announced the commercial launch of its first multiplex test using the company’s proprietary high-definition polymerase chain reaction technology. The HDPCR Tick-Borne Pathogen Panel detects nine of the most common tick-borne pathogens from whole blood specimens in less than four hours. Key features of the panel, the company reports, include seamless integration onto common qPCR instrumentation, scalable throughput, and streamlined data analysis, management, and test customization with ChromaCode Cloud software. The TBP panel is for research use only.
Pages: 1 2